Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Published on 03/05/202503/05/2025 by Research Hypothesis

Jim Sheu | Medicine and Health Sciences | Hypothesis Achievement Award

Prof Jim Sheu, National Sun Yatsen University, Taiwan

Prof. Jim Sheu is a distinguished biomedical scientist with over two decades of academic and research excellence in life sciences. Holding a Ph.D. in Life Science from National Tsing-Hua University (2002), he has consistently advanced the frontiers of molecular oncology, stem cell therapy, and women’s reproductive health. Currently a professor at National Sun Yat-sen University, Taiwan, he has previously held prestigious research and academic positions at China Medical University and Johns Hopkins Medical Institutions. He is widely recognized for his role in leading innovative biomedical projects and mentoring the next generation of scientists. Prof. Sheu has made pioneering contributions to cancer genomics, glioblastoma therapeutics, and endometriosis research. His prolific publication record and multiple awards underline his leadership and innovation in the field. His work bridges translational research with clinical applications, shaping modern therapeutic strategies.

Publication Profile

Google Scholar

Education

Prof. Jim Sheu’s educational journey laid a strong foundation for his impactful scientific career. He earned his Ph.D. in Life Science from the prestigious National Tsing-Hua University, Taiwan, in 2002 🧬. This doctoral training provided him with deep expertise in molecular biology, genetics, and biomedical research. Prior to that, he completed his B.S. in Biology from Fu-Jen University, Taiwan, in 1994 🧪. The rigorous academic environment at these institutions honed his critical thinking and experimental skills. His thesis and postdoctoral work involved advanced molecular techniques and translational research applications. With education deeply rooted in cellular biology and medical biotechnology, Prof. Sheu has seamlessly integrated his academic background with real-world research, evolving into a leading expert in cancer biology, stem cell therapies, and women’s health. His academic excellence has continued to inspire his students and collaborators across various institutes.

Experience

Prof. Sheu’s career spans academia, clinical research, and biotechnology. Since 2014, he has served as Professor at the Institute of Biomedical Sciences, National Sun Yat-sen University 🏫. Previously, he held multiple roles at China Medical University (2006–2014), including Researcher, Professor, Associate Professor, and Assistant Professor in the Graduate Institute of Chinese Medical Science 🧑‍🏫. His early international experience includes being a Research Fellow at Johns Hopkins Medical Institutions (2004–2006) 🔬. He also held leadership positions at Taiwan’s Development Center for Biotechnology (2003–2004), directing and managing key protein drug and biomedicine projects. His academic and research trajectory is marked by interdisciplinary innovation, integrating biomedical engineering, genetics, and pharmacology. Prof. Sheu’s deep involvement in translational research and collaborative initiatives underpins his reputation as a scientific leader in Taiwan and beyond.

Awards & Honors

Prof. Sheu has earned several prestigious honors celebrating his research excellence and innovation. In 2023, he was part of the award-winning Biomedical Team at National Sun Yat-sen University for a serum-free stem cell medium at the NBRP Pitch Day 🧫🏅. He also received the Outstanding Faculty of Basic Research award and the Tien-Te Lee Award for an outstanding poster on stem cell therapies for Parkinson’s disease. In 2022, he was honored by the Taiwan Endometriosis Society for his research using traditional medicine to modulate immune responses 🌿🧠. Additionally, he won the Prof. Chii-Ruey Tzeng Award for an impactful paper in endometriosis research. These accolades highlight Prof. Sheu’s interdisciplinary impact, bridging traditional Chinese medicine, molecular biology, and cutting-edge therapeutic development. His continuous recognition by scientific communities underscores his leadership in biomedical innovation.

Research Projects

Prof. Jim Sheu has actively contributed as a project reviewer in the field of life sciences since 2012 🌱. He serves the National Science and Technology Council (NSTC) in Taiwan and has reviewed projects for various institutions including Tri-Service General Hospital (2021–present), Kaohsiung Veterans General Hospital (2021–present), and Zuoying Armed Forces General Hospital (2020–present) 🏥. He also evaluated projects for National Tsing-Hua University (2023) and Kaohsiung Chang Gung Smart Hospital (2022) 🎓. His expertise has extended globally, reviewing for Italy’s Ministry of Health in 2015 🇮🇹 and South Africa’s Medical Research Council in 2012 🇿🇦, showcasing his international recognition 🌍.

Research Focus

Prof. Sheu’s research is centered on cancer biology, stem cell therapy, gynecological diseases, and translational medicine. He explores the molecular mechanisms of tumor progression, particularly in microsatellite instability and glioblastoma 🔍🧠. His investigations into ethnic-specific genetic markers for endometriosis and ovarian aging highlight his commitment to personalized medicine. Another focus lies in the regulation of immune responses using traditional herbal compounds, bridging modern molecular science with Eastern medicine 🌿🧪. He has led multi-omics studies that decode complex disease pathways, including mitochondrial dysfunction in breast cancer. Additionally, he is advancing serum-free stem cell enhancement technologies aimed at clinical application. Prof. Sheu’s interdisciplinary approach links genomics, proteomics, and pharmacology, translating basic research into viable therapeutic strategies. His work significantly contributes to understanding cellular aging, reproductive biology, and cancer therapy.

Publication Top Notes

Functional genomic analysis identified epidermal growth factor receptor activation as the most common genetic event in oral squamous cell carcinoma

Amplification of a chromatin remodeling gene, Rsf-1/HBXAP, in ovarian carcinoma

A BTB/POZ protein, NAC-1, is related to tumor recurrence and is essential for tumor growth and survival

Puerariae radix isoflavones and their metabolites inhibit growth and induce apoptosis in breast cancer cells

Autophagy and its link to type II diabetes mellitus

Talin‐1 overexpression defines high risk for aggressive oral squamous cell carcinoma and promotes cancer metastasis

Kaempferol inhibits enterovirus 71 replication and internal ribosome entry site (IRES) activity through FUBP and HNRP proteins

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Published on 28/04/202528/04/2025 by Research Hypothesis

Shalini Singh | Medicine and Health Sciences | Best Researcher Award

Research Scholar, Gurukul Kangri, Deemed to be University, Haridwar, India

Mrs. Shalini Singh 🌸 is a highly accomplished scientific writer and researcher specializing in phytopharmacology 🌿, herbal medicine 🌼, and integrative therapeutics 🧪. With a Master’s in Pharmacology 🎓 and currently pursuing her Ph.D. 🎯 at Gurukula Kangri University, Haridwar, she has made outstanding contributions to academic and regulatory scientific writing 📚. She worked at Patanjali Research Foundation 🌱 from 2018-2022, authoring numerous high-impact peer-reviewed articles, monographs, and dossiers. Mrs. Singh has collaborated with multidisciplinary teams 👩‍🔬, contributed to national and international initiatives like NMCG and AYUSH 🌍, and reviewed for top journals like Elsevier and Springer 📝. Her work bridges traditional wisdom and modern science, embodying excellence 🌟, dedication 💪, and innovation 💡. She continues to inspire through her research, scientific integrity, and pursuit of holistic healthcare solutions 🌏.

Publication Profile

Orcid

Experience

Mrs. Singh is a skilled Scientific Writer 🖋️ who worked at Patanjali Research Foundation, Haridwar (May 2018–Nov 2022), where she authored peer-reviewed articles 📄, pharmacological monographs 📑, systematic reviews 📚, and regulatory documents 🏛️. She specialized in herbal medicine 🌿, clinical data analysis 📊, and scientific dossier preparation, demonstrating a strong command over both scientific detail and regulatory standards. Earlier, she served as an Assistant Professor 🎓 at Lords International College of Pharmacy, Alwar (Dec 2017–April 2018), engaging in teaching 📚, mentoring students 🎯, curriculum development ✍️, and academic research 🧪. Throughout her career, Mrs. Singh collaborated with interdisciplinary teams 🤝, reviewed manuscripts for leading journals 📰, and contributed to national projects initiated by the Ministry of AYUSH and the NMCG 🌐. Her work consistently reflects a unique blend of scientific rigor 🔬, exceptional communication skills 🗣️, and regulatory precision 📏, establishing her as an invaluable asset to the research community.

Awards and Honors

Mrs. Shalini Singh exemplifies academic excellence 📚, leadership 🏅, and a deep commitment to advancing healthcare research and Ayurvedic sciences 🌿. As a dedicated peer reviewer 🖊️ for prestigious journals like Elsevier, Springer, Wiley, Bentham Science, and Frontiers 🌍, she actively contributes to the scientific community. She has participated 🎤 in multiple national and international conferences 🌏, including “Modernization of Traditional Indian Medicine” 🌱, “Emerging Scenario of Science, Technology & Innovation-2023” 🔬, and “Plants to Patients – Series 3: Rethinking Ethnopharmacology” 🌸. Her scholarly engagements extend further with her successful completion 🏆 of the DST-Sponsored STUTI Training Program at SATHI-BHU, Varanasi 🎓. Mrs. Singh’s numerous participations, invited talks, and reviewer roles highlight her dynamic presence in the academic world, showcasing her drive to foster innovation and interdisciplinary collaboration. Her work continues to impact the fields of ethnopharmacology and traditional medicine, inspiring future researchers and practitioners alike 🌟.

Research Focus

Mrs. Shalini Singh’s research centers around phytopharmacology 🌱, herbal medicine 🌿, ethnopharmacology 🧬, and integrative therapeutics 💊. She has explored the anti-diabetic 🌟, anti-inflammatory 🧪, and wound healing 🩹 potentials of natural products and traditional herbs. Her interest extends to modernizing Ayurvedic treatments 🧘‍♀️ through evidence-based studies, clinical evaluation 📊, and data synthesis from ethnobotanical sources 📚. She has worked on national and global projects 🌏, authoring scientific dossiers, monographs, and manuscripts that bridge the gap between traditional medicine and contemporary healthcare practices 🧠. In addition to primary research, she emphasizes scientific communication 🖋️, regulatory documentation 📑, and the development of novel therapeutics 🚀, making her a key player in promoting holistic, sustainable healthcare innovation 🌼.

Publication Top Notes

Research Articles:

📄 Evaluation of Anti-Diabetic activity of fruits of Withania coagulans in streptozotocin-induced diabetic rats.
📄 Anti-Hyperglycemic activity of Pithecellobium dules plant extracts on blood glucose levels of streptozotocin-induced diabetic rats.
📄 Effectiveness of Ayurvedic Regimens in Managing Polycystic Ovarian Syndrome and Related Comorbidities: An Observational Study.
📄 Exploring the Role of Herbo-mineral Combinations for the Management of Hypothyroidism.
📄 Elevating the Inner-Consciousness “Third Eye” Through “Vedic Manas Yoga” Practice.
📄 Effect of various extracts from Ficus retusa L. stem bark on wound healing potential.

Review Articles:

📚 Ayurvedic Approaches to Managing Premature Greying of Hair: A Comprehensive Review.
📚 Small molecule inhibitors target multiple neuropathological signaling to exert novel neuroprotection in intracranial aneurysms.
📚 Nature’s Signature in Ayurveda with an Ethnopharmacological Approach: A Narrative Review.
📚 Nanotechnology in the Diagnosis and Management of Polycystic Ovary Syndrome: A Systematic Scoping Analysis.
📚 Impact of Biosensors and Biomarkers in Diabetes Care: A Review.
📚 Swertia chirayita (Roxb.) H. Karst.: A Magnificent Natural Remedy for Gastrointestinal Disorders.
📚 Effect of Coliform Bacteria on Various Environmental Factors: A Review.
📚 Hazardous Consequences and Management of Heavy Metals in Sewage Sludge: An Overview.
📚 Withania coagulans Dunal.: A Narrative Review of an Anti-diabetic Shrub of the Desert Biome.
📚 Bartogenic Acid: A Promising Pentacyclic Triterpenoid in Cancer Research and Possible Mechanism.

Yuanli Zhang | Medicine and Health Sciences | Best Researcher Award

Published on 24/04/202524/04/2025 by Research Hypothesis

Yuanli Zhang | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr Yuanli Zhang, Chongqing Three Gorges Medical College, China

Assoc. Prof. Dr. Yuanli Zhang is a distinguished academic and the Deputy Secretary of the School of Medical Technology at Chongqing Three Gorges Medical College 🇨🇳. With over a decade of dedication to the field of oral biomechanics 🦷🧠, he has significantly advanced knowledge in orthodontics, implantation, and jaw surgery. Dr. Zhang has published more than 20 peer-reviewed papers 📚 and is a lead contributor to several innovative research projects focused on temporomandibular joint (TMJ) dysfunction, integrating engineering and medicine 🤖🧪. He also holds multiple national patents 🧾, reflecting his innovative work in dental biomechanics and medical imaging. His scholarly books, including one published by CRC Press, are used widely in the field. Dr. Zhang’s commitment to research excellence, innovation, and education marks him as a leading figure in biomedical engineering and dental science 🏅.

Publication Profile

Orcid

Education

Dr. Yuanli Zhang holds a rigorous academic background in biomechanics and medical engineering ⚙️🩺. He completed his undergraduate and postgraduate studies in biomedical-related disciplines, focusing on musculoskeletal system analysis and oral-maxillofacial biomechanics. His expertise has been deepened through advanced studies in computational modeling and finite element analysis 💻📐. Dr. Zhang’s education combines theoretical knowledge with hands-on research experience, especially in the simulation and mechanical evaluation of the temporomandibular joint (TMJ). He has also received extensive training in the application of ABAQUS finite element software, which he later translated into a best-selling textbook. His academic formation laid a strong foundation for multidisciplinary collaboration across medicine, dentistry, and mechanical engineering 🤝. This comprehensive educational pathway has empowered him to design and execute complex research projects and contribute meaningfully to both clinical and academic communities 🏫📖.

Experience

Assoc. Prof. Dr. Yuanli Zhang currently serves as the Deputy Secretary of the School of Medical Technology at Chongqing Three Gorges Medical College 🏫. With over ten years of research and academic leadership experience, he specializes in oral biomechanics, integrating clinical insights with mechanical engineering principles 🦷⚙️. He has directed numerous research projects on TMJ dysfunction, prosthodontics, and jaw surgery, often collaborating across departments and disciplines 🌐. Dr. Zhang is also a consultant in industrial biomechanics projects involving denture material strength testing and fatigue performance evaluation 🔍🧪. In addition to his administrative duties, he regularly mentors students, coordinates research labs, and publishes in high-impact journals. His dual role in academia and applied research makes him a valuable contributor to innovations in oral healthcare, implantology, and diagnostic imaging technologies 📊🧠.

Awards and Honors

Dr. Zhang’s trailblazing work in oral biomechanics has been recognized through numerous patents and academic accolades 🥇. His book Computational Biomechanics of the Musculoskeletal System is a highly cited reference in the field and showcases his authority on the subject 📘. He was awarded national patents for innovations such as MRI examination aids, implant prosthetics, and medical imaging equipment 🔬📸. These inventions reflect his problem-solving approach to real-world medical challenges. Dr. Zhang has also been honored for his role in translational research, converting complex engineering principles into practical clinical tools. While formal award citations may not be listed, his prolific publication record, interdisciplinary collaborations, and contributions to medical device development are evidence of his scholarly excellence and research leadership 💡🏅. His profile stands strong for the Best Researcher Award based on both innovation and academic impact.

Research Focus

Dr. Yuanli Zhang’s research centers on the biomechanical dynamics of the temporomandibular joint (TMJ) and the clinical implications of dental procedures such as implantation, prosthodontics, and jaw surgeries 🦷🔍. His work bridges engineering mechanics and oral medicine, offering critical insights into TMJ dysfunction caused by surgical interventions or prosthetic usage 🧠⚙️. Utilizing advanced finite element analysis (FEA) and 3D modeling software, Dr. Zhang evaluates stress distributions, joint morphology, and bite force dynamics 💻📊. His research has clinical relevance in reducing patient discomfort, improving surgical outcomes, and guiding personalized treatment planning. Ongoing projects include exploring GDF11 expression in cancer, the effect of implants on TMJ health, and the design of more adaptive oral prosthetics 🧬🧪. His interdisciplinary methodology supports innovations in diagnostic tools and therapeutic strategies, making his research both timely and transformative for the field of biomedical engineering and dental science.

Publication Top Notes

The Effect of Dental Implant Restoration on the Biomechanics of the Temporomandibular Joint in Patients with Posterior Tooth Loss: A Pilot Study

The impact of posterior tooth loss on the biomechanics of the temporomandibular joints

Morphological study of the changes after sagittal split ramus osteotomy in patients with facial asymmetry: measurements of 3-dimensional modelling

Comparison of Morphologic Parameters of Temporomandibular Joint for Asymptomatic Subjects Using the Two-Dimensional and Three-Dimensional Measuring Methods

Morphologic analysis of the temporomandibular joint between patients with facial asymmetry and asymptomatic subjects by 2D and 3D evaluation: A preliminary study

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Published on 23/04/202523/04/2025 by Research Hypothesis

YONGFANG HU | Medicine and Health Sciences | Best Researcher Award

Assoc. Prof. Dr YONGFANG HU, Beijing Tsinghua Changgung Hospital, China

Assoc. Prof. Dr. Yongfang Hu is a distinguished clinical pharmacist and academic with over three decades of impactful service in pharmacy and pharmacology. 📚🧬 She earned her degrees from Lanzhou University and Central South University, focusing on pharmacology and clinical pharmacology. 💊 She has held prominent roles at leading institutions such as Lanzhou University, Peking University Third Hospital, and Tsinghua Changgung Hospital. 🌟 Her pioneering research covers pharmacogenomics, organ transplant pharmacotherapy, and elderly care medication. 🧠💉 A highly respected scholar, she has authored influential publications and led studies on multidrug-resistant infections and personalized medicine. 📈🧫 Dr. Hu’s commitment to advancing safe, effective drug therapies makes her a standout candidate for the Best Researcher Award. 🌐🥇

Publication Profile

Orcid

Education

Dr. Yongfang Hu’s academic journey began with a Bachelor’s Degree in Pharmacy from the School of Pharmacy, Lanzhou University (1988). 🎓💊 She further pursued a Master’s Degree in Pharmacology from the same institution in 2000, deepening her understanding of drug mechanisms and therapeutic strategies. 🔬📘 To solidify her expertise in clinical applications, she earned a Doctorate in Clinical Pharmacology from the Institute of Clinical Pharmacology, Central South University (2005). 🧬📖 Her academic training spans fundamental pharmacy, experimental pharmacology, and patient-centered pharmacotherapy, laying a strong foundation for her research in genomics, drug therapy, and personalized medicine. 🧠🧪 Each milestone in her educational path reflects her lifelong dedication to pharmacological sciences and clinical excellence. 🏅📚

Experience

From 1988 to 2002, Dr. Hu served as a Deputy Chief Pharmacist and Associate Professor at the Second Affiliated Hospital of Lanzhou University. 🏥📘 She later joined Peking University Third Hospital (2005–2014) as a Chief Pharmacist and Associate Professor, advancing clinical pharmacy services and academic programs. 🧪📈 Between 2014 and 2015, she led the Pharmacy Department at Tsinghua Changgung Hospital, and since 2015, she continues there as a Chief Pharmacist and Associate Professor of Clinical Pharmacy. 🧬🏥 Her clinical and academic leadership across top Chinese institutions showcases her expertise in implementing advanced pharmaceutical care and mentoring future pharmacists. 💡🎓

Awards and Honors

Dr. Hu has received multiple recognitions for her excellence in pharmacy and research. 🏆 In her tenure, she has been honored with Institutional Excellence Awards for Clinical Pharmacy Innovation and Outstanding Research Contributions at Peking University Third Hospital and Tsinghua Changgung Hospital. 🎖️ She has been invited to serve on editorial boards and academic review committees, reflecting her standing in the scientific community. 📚👩‍⚕️ Her extensive work on drug genomics and personalized medicine has earned her accolades at national pharmacology conferences. 🧬🌟 These honors signify her continuous impact on both patient care and the broader medical research landscape. 🧠🏅

Research Focus

Dr. Hu’s research primarily focuses on the genomics of organ transplantation drugs and pharmacogenomics of thromboembolic diseases. 🧬🫀 She explores how genetic variations influence drug responses, aiming to tailor therapies for optimal patient outcomes. 🧠💊 She also delves into drug therapies for infectious diseases, including strategies to combat multidrug-resistant organisms, particularly in transplant patients. 🧫🛡️ Her work extends to cardiovascular pharmacotherapy and medication optimization in the elderly population, tackling polypharmacy and age-related metabolic changes. 👵❤️ Through clinical studies and predictive modeling, Dr. Hu drives personalized medicine in real-world settings. 📊🔍 Her interdisciplinary approach bridges pharmacology, genomics, and patient care. 🌐🔗

Publication Top Notes

Epidemiology and Risk Prediction Model of Multidrug-Resistant Organism Infections After Liver Transplant Recipients: A Single-Center Cohort Study 🧫🧬

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Published on 22/04/202522/04/2025 by Research Hypothesis

Yong Ahn | Medicine and Health Sciences | Best Researcher Award

Prof. Dr Yong Ahn, Kyung Hee University Hospital, Kyung Hee University College of Medicine at Gangdong, Kyung Hee University College of Medicine, South Korea

Prof. Dr. Yong Ahn is a globally recognized leader in minimally invasive spine surgery. Having earned his MD and PhD from Seoul National University School of Medicine, Dr. Ahn has devoted his career to advancing surgical techniques that minimize patient recovery time and improve outcomes. Currently serving as President of Wooridul Spine Hospital, he also heads the Department of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn’s distinguished contributions are acknowledged worldwide, as reflected in his inclusion in MARQUIS Who’s Who and receipt of the Albert Nelson Marquis Lifetime Achievement Award. He holds pivotal roles in several spine surgery societies, chairs editorial boards for prestigious journals, and actively shapes the field through extensive research and publication. His dedication and innovations make him an exemplary candidate for the Best Researcher Award.

Publication Profile

Orcid

Education

Prof. Dr. Yong Ahn completed both his MD and PhD at the prestigious Seoul National University School of Medicine in Korea. Beyond his medical degrees, he expanded his expertise internationally, becoming a Fellow of the American Board of Minimally Invasive Spinal Surgery and the Royal College of Physicians and Surgeons. His educational background is marked by a combination of rigorous academic training and a forward-looking vision for medical innovation. Dr. Ahn’s academic pursuits laid a strong foundation for his pioneering work in minimally invasive techniques and spinal endoscopy, fields in which he would later become a leading authority. His commitment to lifelong learning and professional development exemplifies the values necessary for outstanding contributions to medical science.

Experience

Dr. Yong Ahn has had an illustrious career, marked by leadership and innovation in spine surgery. He currently serves as the President of Wooridul Spine Hospital and as Head of Neurosurgery at Armed Forces Chungpyung Hospital. Dr. Ahn also plays critical roles in academic societies, including being Chairperson of the Korean Endoscopic Spine Surgery Society and Scientific Manager of the Korean Minimally Invasive Spine Surgery Society. His expertise extends to national policy, where he serves on the Inter-Ministerial Evaluation Committee for national R&D projects. As Editor-in-Chief of JMISST-Video and an editorial board member of European Spine Journal, Biomed Research International, and PLOS One, he influences scientific communication globally. His experience is distinguished by a balance between surgical excellence, academic leadership, and contributions to national and international healthcare systems.

Awards and Honors

Prof. Dr. Yong Ahn’s outstanding achievements have been recognized through numerous prestigious awards. He received the Gachon University President’s Special Award for Research Excellence in 2020, honoring his significant research contributions. In 2018, he was awarded the Albert Nelson Marquis Lifetime Achievement Award, further confirming his global impact. Dr. Ahn’s inclusion in the MARQUIS Who’s Who reflects his longstanding influence and excellence in the field of spine surgery. His leadership positions within various professional societies and editorial roles also signify peer recognition of his professional authority and contributions. Each award not only celebrates his past accomplishments but also highlights his continuing commitment to advancing medical science and patient care.

Research Focus

Dr. Yong Ahn’s research focuses primarily on minimally invasive spine surgery and endoscopic procedures. He is a pioneer in developing techniques that allow complex spinal conditions to be treated with reduced surgical trauma, faster recovery, and improved patient outcomes. His studies address critical topics such as the learning curve associated with minimally invasive techniques, surgical complications like dural tears, and innovations in endoscopic decompression procedures. Dr. Ahn’s research bridges clinical practice and technological advancement, making significant strides in the refinement of surgical methods. As an editor and author of core textbooks in his field, he also contributes to education and knowledge dissemination. His commitment to evidence-based practice ensures that his research directly benefits both the scientific community and patients worldwide.

Publication Top Notes

Magnetic Resonance Imaging Predictors of Surgical Difficulty in Transforaminal Endoscopic Lumbar Discectomy for Far-Lateral Disc Herniation Under Local Anesthesia

A Commentary on “Full-Endoscopic Resection of a Lumbar Intradural Tumor (Schwannoma): Video Case Report and Description of the Surgical Technique”

Transforaminal Endoscopic Lumbar Foraminotomy for Iatrogenic Foraminal Stenosis Following Vertebroplasty

Access Pain During Transforaminal Endoscopic Lumbar Discectomy for Foraminal or Extraforaminal Disc Herniation

Access Pain during Transforaminal Endoscopic Lumbar Discec-Tomy for Foraminal or Extraforaminal Disc Herniation

Learning Curve for Endoscopic Transsphenoidal Surgery: A Systematic Review and Meta-Analysis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Published on 21/04/202521/04/2025 by Research Hypothesis

Bruno Songel Sanchis | Medicine and Health Sciences | Best Review Paper Award

Mr Bruno Songel Sanchis, Hospital clínico San Carlos, Spain

Mr. Bruno Songel Sanchis 🎻👓 is a versatile professional with dual expertise in music and vision sciences. Holding a Master’s in Optometry and Vision Sciences from the Complutense University of Madrid 🎓, and a degree in Optics and Optometry from the University of Valencia, he seamlessly combines clinical acumen with research innovation. His extensive clinical experience spans Hospital Clínico San Carlos and Fundación Salud Visual, focusing on cutting-edge myopia control, glaucoma diagnostics, and AI integration in ophthalmology 🤖🧠. Beyond clinics, Bruno’s passion for community service is evident through his impactful volunteer roles and outreach projects 🫶. A talented cellist 🎶 and a committed scientist, he bridges the gap between art and science with grace and dedication. His systematic review on ocular manifestations in IBD showcases his research depth 📄📊. A creative thinker and empathetic clinician, Bruno is a promising contender for the Best Review Paper Award 🥇🧬.

Publication Profile

Orcid

Education

Bruno Songel Sanchis has a rich and interdisciplinary educational background 🎓✨. He earned his Professional Degree in Music (Violoncello) from the Professional Music Conservatory of Valencia 🎻, showcasing his artistic talents. He later pursued a Scientific Baccalaureate at San José de Calasanz High School 🧪📘. Bruno’s scientific journey led him to the University of Valencia, where he obtained his Degree in Optics and Optometry 👁️📐. Committed to advancing vision care, he continued with a Master’s Degree in Optometry and Vision Sciences at the prestigious Complutense University of Madrid 👓🔬. He’s currently engaged in Project Efficiency Boost (2025–present), enhancing clinical productivity through AI and innovation 🚀🤖. His academic versatility reflects both analytical rigor and creativity, a rare blend that empowers his impactful work in clinical practice and scientific research 🧠📚.

Experience

Bruno has extensive hands-on experience in both clinical and research settings 🏥🔬. He served as a Clinical Optometrist at Hospital Clínico San Carlos (Madrid), rotating across subspecialties like myopia, retina, glaucoma, and cataracts 👁️💉. He contributed to pivotal research on myopia control with Atropine and later as a Clinical Research Technician at IdISSC, focused on the ‘LYDIA project’ developing AI diagnostic tools 🤖📊. His role as a Product Specialist marked a major milestone—implementing Europe’s first AI-powered ophthalmic imaging system at La Paz Hospital 🏥✨. Earlier, he worked at Óptica Universitaria and Alain Afflelou, gaining practical skills in optometry, sales, and customer care 🛠️🛍️. Bruno also holds a current role at Fundación Salud Visual (Funsavi), continuing his clinical contributions while mentoring others. These experiences shape him into a well-rounded professional with deep clinical knowledge, technical skills, and patient-centered care focus 👓🫶.

Awards and Honors

Bruno Songel Sanchis has garnered multiple honors for both creativity and scientific excellence 🏆📚. He won 1st prize in the UV Creative Outreach Project (2021) for innovative public science engagement 🎨💡. At the UVemprén Startup – Crea Awards, he secured 3rd position for his entrepreneurial vision in healthcare 🔬🚀. His musical talents earned him an Honorable Mention Diploma at an International Music Seminar, reflecting his multifaceted abilities 🎶🏅. He was also a Finalist in the MOTIVEM UV Awards, acknowledging his academic initiative and leadership 📘👏. As a Rapporteur at the SIYO 2022 Congress for Young Optometrists, he showcased his ability to bridge science and communication 🗣️📊. His certifications from the London School of Hygiene and Tropical Medicine in public health ophthalmology further validate his global competence in preventing blindness and tackling ocular diseases on an international level 🌍👁️.

Research Focus

Bruno Songel Sanchis’s research focuses on clinical optometry, ocular disease prevention, and artificial intelligence applications in ophthalmology 🧠👁️🤖. His major interests include myopia control, particularly using Atropine-based treatments, and early detection of age-related macular degeneration and glaucoma through AI-powered diagnostic systems 🧬📈. In collaboration with top-tier hospitals and research institutions, Bruno played a pivotal role in developing multi-diagnostic tools and conducting clinical trials on visual pathologies. His review on ocular extraintestinal manifestations in inflammatory bowel disease (IBD) offers critical insights into interdisciplinary patient care 📄🩺. A blend of practical clinical work and technical innovation defines his approach, with the goal of improving accessibility and effectiveness of vision care globally 🌐✨. His ongoing contributions to AI integration, coupled with community eye health initiatives, make him a forward-thinking optometrist and researcher committed to impactful, data-driven healthcare advancements 🩻📊.

Publication Top Notes

Analysis of the Incidence of Ocular Extraintestinal Manifestations in Inflammatory Bowel Disease Patients: A Systematic Review (2024)

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Published on 16/04/202516/04/2025 by Research Hypothesis

Yu Pan | Medicine and Health Sciences | Young Scientist Award

Dr Yu Pan, Fujian Medical University Union Hospital, China

Dr. Yu Pan is a pioneering medical scientist and attending physician at the Department of General Surgery, Fujian Medical University Union Hospital, China. His groundbreaking research bridges immunotherapy and pancreatic cancer treatment, focusing on mechanisms shaping the tumor microenvironment and translating them into clinical applications. As the principal investigator of multiple prestigious grants, Dr. Pan leads a laboratory exploring mRNA vaccine development and immune regulation in pancreatic malignancies. With over a dozen high-impact publications, including in Nature Nanotechnology and JITC, his work is rapidly transforming the therapeutic landscape. An active mentor and educator, he has guided eight Master’s students, several of whom now pursue PhDs or hold clinical positions at top hospitals. Recognized for academic excellence and innovation, Dr. Pan exemplifies the qualities of a future leader in oncology and immunology. His contributions reflect a deep commitment to both science and society.

Publication Profile

Orcid

Education

Dr. Yu Pan is a dedicated medical professional with a strong academic background in Medical Sciences 🧠🔬. He began he journey in medicine at Anhui Medical University, China, where he earned he Bachelor’s degree between 2008 and 2013 🎓🇨🇳. He passion for advancing healthcare led he to pursue further studies at Fujian Medical University. From 2014 to 2017, he completed he Master’s degree in Medical Sciences, specializing in General Surgery 🏥🩺. Demonstrating exceptional commitment to surgical research and clinical excellence, Dr. Pan continued at the same university to obtain her Ph.D. in Medical Sciences from 2017 to 2020 🎓🔍. During her academic career, she gained extensive experience in surgical techniques, research methodologies, and patient care, contributing significantly to the field of general surgery 📚. He educational path reflects a continuous pursuit of knowledge and skill development, underscoring he role as a dedicated surgeon and researcher committed to medical innovation and patient well-being ❤️‍🩹.

Experience

Dr. Yu Pan is a dedicated surgical professional with extensive experience in clinical practice, teaching, and mentorship. From 2020 to 2022, Dr. Pan completed a surgical residency at the Department of Surgery, Fujian Medical University Union Hospital 🏥. Since 2022, he has served as a Staff Attending Physician in the Department of General Surgery 👨‍⚕️. Alongside his clinical duties, Dr. Pan has been actively involved in teaching as an Instructor for Clinical Skills Training Classes (2022–2024) at Fujian Medical University 🎓. He has also served as a thesis advisor for Master’s students since 2021, mentoring eight students in total. Five have graduated, with three pursuing PhDs and two now practicing at top institutions, including Jinhua Hospital and Fudan University Shanghai Cancer Center 🎯. His mentees have published in prestigious journals such as JITC, Functional Integrated Genomics, Frontiers in Pharmacology, and Cell Death & Disease 📚🔬, reflecting Dr. Pan’s strong academic impact.

Awards and Honors

Dr. Yu Pan is a highly accomplished medical researcher recognized for his consistent contributions to science and healthcare advancement 🧬🩺. He currently leads the 2025 Overseas Study Program for Young and Middle-Aged Medical Talents in Fujian Province 🌏✨. In 2023, he was selected for the Excellent Young Scholars Cultivation Project by Fujian Medical University Union Hospital (No. 2022XH025) 🧑‍🔬🏅. His expertise earned national recognition through the prestigious 2021 National Natural Science Foundation of China grant (No. 82103310) 🇨🇳🔍. That same year, he secured funding from the Natural Science Foundation of Fujian Province (No. 2021J01774) and played a pivotal role in the Joint Funds of the Scientific and Technological Innovation Program of Fujian Province (No. 2020Y9081) 💡🔬. Additionally, Dr. Pan led the 2020 Fujian Provincial Health Technology Project (No. 2020GGA029), further highlighting his dedication to medical research and innovation in the region.

Research Focus

Dr. Yu Pan’s research centers on pancreatic cancer and inflammatory-immune responses, with a strong emphasis on immune regulation, tumor microenvironment, and therapeutic targets 🧬🩸. His studies explore the role of Annexin A1, CD47-targeted therapies, and immune checkpoints in pancreatic disorders, especially pancreatic ductal adenocarcinoma (PDAC) and neuroendocrine neoplasms 🧫🧠. Through single-cell analysis, preclinical models, and clinical translation, Dr. Pan investigates how immune dynamics shape disease progression and treatment outcomes 🧪📊. His work contributes significantly to immunotherapy and precision medicine in gastrointestinal oncology, aiming to improve prognosis and treatment for patients with severe pancreatic conditions 💊🧠🧑‍⚕️.

Publication Top Notes

Annexin A1 regulates inflammatory-immune response and reduces pancreatic and extra- pancreatic injury during severe acute pancreatitis

Translating CD47-Targeted Therapy in Gastrointestinal Cancers: Insights from Preclinical to Clinical Studies

The prognostic and therapeutic value of the tumor microenvironment and immune checkpoints in pancreatic neuroendocrine neoplasms

Loss of Annexin A1 in macrophages restrains efferocytosis and remodels immune microenvironment in pancreatic cancer by activating the cGAS/STING pathway

High-dimensional single-cell analysis unveils distinct immune signatures of peripheral blood in patients with pancreatic ductal adenocarcinoma

Single-cell RNA sequencing revealed subclonal heterogeneity and gene signatures of gemcitabine sensitivity in pancreatic cancer

Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer

Nathalia Castillo | Medicine and Health Sciences | Best Researcher Award

Published on 28/03/202528/03/2025 by Research Hypothesis

Nathalia Castillo | Medicine and Health Sciences | Best Researcher Award

Ms Nathalia Castillo, Albany Medical College, United States

Ms. Nathalia Castillo is a dedicated medical student and researcher at Albany Medical College, with a profound commitment to transplant surgery, orthopedic surgery, and healthcare disparities. She has showcased exceptional leadership, guiding multiple research initiatives while advocating for healthcare equity. Her studies focus on addressing racial and gender disparities in surgical fields, ensuring improved patient outcomes. Through her contributions to academic research, medical education, and leadership roles, she has established herself as an emerging scholar in the medical field. Ms. Castillo’s work has been recognized at national conferences, and she actively mentors fellow students in surgical research. She remains dedicated to advancing knowledge and bridging gaps in healthcare.

Publication Profile

Scopus

Education

Ms. Nathalia Castillo is currently an MD candidate at Albany Medical College, expected to graduate in May 2025. She completed her Bachelor of Science in Health Science with a minor in Nutrition from Chapman University, where she graduated Summa Cum Laude (2021) 🏅. During her undergraduate studies, she actively engaged in research projects focused on public health, medical disparities, and clinical outcomes. Her strong academic performance, combined with her commitment to research, led her to pursue surgical investigations at Albany Medical College. Ms. Castillo has also participated in numerous research training programs and medical symposiums, enhancing her skills in biostatistics, data analysis, and clinical trial methodologies 📊. She continues to build a strong foundation in medical research while excelling in academics and leadership roles.

Experience

Ms. Nathalia Castillo has extensive research experience in transplant surgery, orthopedic surgery, and healthcare disparities. She has served as a research leader in the Department of General Surgery and Transplant Surgery at Albany Medical College, where she has worked on groundbreaking studies 📑. Her contributions include research on racial and gender disparities in surgical specialties, leading to impactful findings in healthcare equity. She has collaborated with top surgeons and academic mentors, co-authoring multiple peer-reviewed publications and conference presentations. Additionally, she holds leadership positions in student organizations, such as the Latinx Medical Student Association, advocating for diversity in medicine. Ms. Castillo has also mentored medical students in research methodologies, fostering a new generation of evidence-based practitioners 📚.

Awards and Honors

Ms. Nathalia Castillo’s dedication to medical research and academic excellence has earned her prestigious awards 🏆. She was inducted into the Alpha Omega Alpha Honor Medical Society (2024), a recognition reserved for top medical students based on academic merit and research contributions 🎓. She also received the Scholastic Excellence Award from Albany Medical College, highlighting her outstanding performance. In 2024, she was awarded Top 10 Poster at the American Orthopaedic Association Annual Leadership Meeting 🏅. Her research on surgical disparities has been presented at national and international conferences, earning recognition from leading medical institutions. Ms. Castillo continues to push the boundaries of medical research, ensuring innovation and progress in transplant and orthopedic surgery.

Research Focus

Ms. Nathalia Castillo’s research focuses on transplant surgery, orthopedic surgery, and healthcare disparities 🏥. Her studies aim to identify and address racial and gender disparities in surgical fields, working towards improving access, outcomes, and representation. She has extensively investigated attrition rates among US abdominal transplant surgeons, revealing critical inequalities in leadership positions 📊. Her work in orthopedic surgery explores complication management and surgical outcomes, particularly in foot and ankle procedures 🦶. Additionally, she examines equitable patient care in organ transplantation, ensuring fair access and success rates among underrepresented groups. Her findings have been published in top-tier journals, influencing policy changes and medical education reforms 📚. Ms. Castillo’s passion for bridging gaps in healthcare drives her commitment to evidence-based solutions and advocacy for diversity in surgery.

Publication Top Notes

Is Recognition in Transplant Surgery Equitable? A Two-decade Analysis of Transplant Award Recipients

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Published on 15/03/202515/03/2025 by Research Hypothesis

Mohamed Hassan | Medicine and Health Sciences | Best Researcher Award

Assist. Prof. Dr Mohamed Hassan, Tulane University School of Medicine, United States

Assist. Prof. Dr. Mohamed Hassan is a distinguished researcher in molecular biology, tumor biology, and virology 🧬. His groundbreaking work focuses on tumor progression, cancer stem cell biology, and innovative therapeutic strategies 🎯. With an extensive portfolio of high-impact publications 📄 and supervised doctoral candidates 🎓, his research significantly contributes to understanding melanoma resistance, non-receptor tyrosine kinases, and immune checkpoint inhibitors 🏥. He has collaborated with leading international institutions, enriching the field with novel discoveries in oncology 🔬. His contributions extend beyond research, fostering the next generation of scientists and improving clinical oncology outcomes 🏥.

Publication Profile

Orcid

Education

Dr. Mohamed Hassan earned his Ph.D. in Molecular Biology 🏅 from the University Hospital of Düsseldorf, Germany (2001), where his research focused on the interference of the Hepatitis C Virus (HCV) core protein with intracellular signal transduction in liver cells 🦠. He holds an M.Sc. in Molecular Biology 📖 from the University of Düsseldorf (1996), with a thesis on identifying and characterizing differentially expressed cDNA libraries in Plasmodium malaria chabaudi immune mice 🧪. His academic journey began with a B.Sc. in Biological Sciences 🏫 from Zagazig University, Egypt, and the University of Düsseldorf (1983). His expertise in cancer biology, virology, and molecular research 📊 has established him as a leading researcher in the field.

Experience

Assist. Prof. Dr. Mohamed Hassan is a dedicated cancer researcher with extensive expertise in tumor progression, oncological drug resistance, and precision medicine 🔬💊. He is currently a Senior Postdoctoral Fellow at the Institut National de la Santé et de la Recherche Médicale, University of Strasbourg, France (2018-2025) 🏥. Previously, he served as a Research Assistant Professor at Tulane University School of Medicine, USA (2016-2018) 🎓, and a Postdoctoral Fellow at the University Hospital of Düsseldorf, Germany (2002-2004). His groundbreaking work focuses on identifying biomarkers and developing targeted therapies to enhance cancer treatment worldwide 🌍🧬.

Research Focus

Assist. Prof. Dr. Mohamed Hassan’s research focuses on tumor progression, cancer stem-like cells, and treatment resistance 🧬. His work delves into melanoma’s resistance to standard therapies 🎯, mechanisms of tumor progression and immune evasion 🏥, and targeting cancer stem-like cells to enhance treatment efficacy 💊. He investigates the role of non-receptor tyrosine kinases in oncogenesis 🔬 and explores immune checkpoint inhibitors and their associated cutaneous adverse effects ⚕️. Additionally, his discovery of antimicrobial peptides holds promise for clinical applications 🦠. His contributions drive novel therapeutic strategies, improving cancer treatment outcomes worldwide 🌍.

Publication Top Notes

Reduction of Prostate Cancer Risk: Role of Frequent Ejaculation-Associated Mechanisms

Immune Checkpoint Inhibitor-Associated Cutaneous Adverse Events: Mechanisms of Occurrence

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

<i>hTERT</i> Epigenetics Provides New Perspectives for Diagnosis and Evidence-Based Guidance of Chemotherapy in Cancer

CD133-Dependent Activation of Phosphoinositide 3-Kinase /AKT/Mammalian Target of Rapamycin Signaling in Melanoma Progression and Drug Resistance

Mechanisms of Melanoma Progression and Treatment Resistance: Role of Cancer Stem-like Cells

Induction of Antimicrobial Protein S100A15 Expression by Oral Microbial Pathogens Is Toll-like Receptors-Dependent Activation of c-Jun-N-Terminal Kinase (JNK), p38, and NF-κB Pathways

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Published on 07/03/202507/03/2025 by Research Hypothesis

VIVEKANAND ASHOK | Medicine and Health Sciences | Best Researcher Award

Dr VIVEKANAND ASHOK, Azeezia Health City, India

Dr. Vivekanand Ashok is a dedicated otorhinolaryngologist with a passion for research and surgical excellence. His extensive work spans cochlear implants, otologic surgeries, and head and neck disorders. With numerous high-impact publications in esteemed journals, his research has significantly contributed to advancements in ENT care. His clinical expertise in endoscopic sinus surgery, thyroid disorders, and voice disorders, combined with his academic contributions, makes him a deserving candidate for the Best Researcher Award. His continuous pursuit of innovation in ENT treatments, active participation in conferences, and commitment to medical education further solidify his reputation as an outstanding researcher. 🏅📚🔬

Publication Profile

Orcid

Education

Dr. Vivekanand Ashok 🎓 pursued his MBBS from Azezia Institute of Medical Sciences, Kerala (2014) 🏥📖, followed by an M.S in ENT from Bangalore Medical College and Research Institute, Karnataka (2020) 🎓🩺. He further obtained a DNB (ENT) in 2021 🏅📚 and completed a Fellowship in Cochlear Implant Surgery at GMERS Gandhinagar in 2023 🎧🔬. With a strong foundation in otorhinolaryngology, he specializes in ENT surgeries and cochlear implants, demonstrating his dedication to patient care. His rigorous training at top institutions has equipped him with expertise in handling complex ENT cases, establishing him as a leader in the field. 📘💉🔍

Experience

Dr. Vivekanand Ashok is a distinguished ENT specialist with extensive experience in medical education, clinical practice, and research. He served as a Senior Resident at Karnataka Institute of Medical Sciences (2020-2021) 🏨👨‍⚕️ and Malabar Cancer Centre, Kerala (2021-2022) 🎗️🏥, honing his expertise in otolaryngology. Transitioning into academia, he worked as an Assistant Professor at Karuna Medical College, Kerala (2022-2024) 🎓📖, shaping future medical professionals. Currently, he excels as a Senior Consultant at Co-operative Hospital, Kattappana (2024-2025) 🏨🩺 and Azeezia Health City, Palakkad (2025-Present) ⚕️🔬. His dedication to patient care and surgical excellence makes him a respected figure in the field. 🏆👨‍⚕️

Awards & Honors

Dr. Vivekanand Ashok’s dedication to academic excellence and research has earned him prestigious accolades in the field of ENT. He secured 3rd position in the South Zone ENT Quiz (2018) 🥉🧠, demonstrating his deep knowledge and expertise. In 2019, he was a Zonal Round Participant in the South Zone Young Scholar Award 🎖️📖, further highlighting his commitment to continuous learning and professional growth. These achievements reflect his passion for advancing medical knowledge and contributing to the field of otolaryngology. Through his dedication to research and education, Dr. Ashok continues to make a significant impact in the medical community. 🏆🔬

Research Focus

Dr. Ashok specializes in otorhinolaryngology, cochlear implants, head and neck surgery, and otologic diseases. His research focuses on laryngopharyngeal reflux, rhino-orbital mucormycosis, thyroid carcinomas, and nasal hemangiomas. His work has contributed to improving diagnostic techniques and treatment approaches in ENT disorders. With a passion for innovation, he continues to explore advancements in hearing restoration, sinus surgery, and minimally invasive ENT procedures. 🎧👂📊